Rovia for NRIs

If a large share of your net worth sits in one company's stock, granted as RSUs that vest a few times a year, you already know the quiet anxiety of it. The position grows, the concentration risk grows with it, and the usual choices feel bad: hold and stay exposed to a single ticker, or sell and trigger a tax bill, often while juggling currencies and cross-border rules. Rovia is a newer platform built squarely around that problem, and for equity-rich professionals with one foot in India and one in the US, it is worth understanding what it does and does not do.

The 30-second answer: Rovia is an early-stage wealth platform aimed at people whose wealth is concentrated in company stock, especially RSUs. Per its own site, you connect an existing brokerage such as Morgan Stanley, Fidelity or E*TRADE, sync vested and unvested holdings into one dashboard, transfer shares, and then sell, reinvest or diversify into US stocks and global ETFs to cut concentration risk. It names India-based professionals at US firms, Indians in the US, and returning NRIs as its core members, and references forex costs and cross-border tax as problems it targets. It is newer and still proving itself, so treat its proposition as evolving, read the terms carefully, and verify regulatory protection and country-specific limits before moving any shares or money.

Before going further, it helps to be clear on the underlying question Rovia is trying to answer, which is really about portfolio construction, not just RSUs. If a single stock dominates your holdings, the first thing to understand is how much concentration you can tolerate and what a more balanced mix looks like; the NRI portfolio and asset allocation guide is the right place to ground that thinking before you let any app drive the decision.

What Rovia actually is

Rovia (the operating entity is named on its site as Rovia Innovations Inc.) describes itself as a platform that helps individuals manage, grow and simplify wealth that is tied up in company equity. The pitch is consistent across its pages: your RSUs and stock options are not just compensation, they are an asset you should be able to see clearly, move, and diversify, ideally without heavy forex friction.

The mechanics, as laid out on its "How It Works" page, are four steps. You sign up and pass verification. You connect an existing brokerage or company equity portal, after which vested and unvested RSUs sync into one dashboard. You can transfer shares, with the documentation and cross-border steps handled in the background. And once shares arrive, you can sell, reinvest or diversify into global ETFs and US stocks from the same place.

On the money-handling side, Rovia's site is explicit that it does not hold your assets itself. It states they are held by Alpaca Securities LLC, described as a DTCC member, and that accounts carry SIPC protection up to 500K dollars, with additional insurance referenced. It also describes itself as SEC regulated and cites bank-grade encryption. Its published fee schedule lists a trade execution fee of 0.15 percent (capped at 15 dollars), no stock transfer fee, a 5 dollar withdrawal fee, and no platform fee, last updated 18 February 2026 and subject to change. These are useful, concrete details, but they come from the company itself, so confirm the current numbers and exactly which entity is regulated where before relying on them.

Who it's for

Rovia is openly built for a specific person rather than the general remitter. Its "Who is it for" page names four groups: India-based professionals working for US companies, Indian professionals living in the US, returning NRIs, and a broader global workforce at US firms. The common thread is meaningful equity compensation and a cross-border life, where holdings, taxes and currencies all sit in more than one country at once.

If that is you, the appeal is a single consolidated view of equity that is otherwise scattered across an employer portal and a brokerage, plus tools to act on it. The calculators for RSUs, the "advantage" comparison, and tax-loss harvesting are aimed at the same audience, helping you reason about when to sell and how to manage the tax drag of diversifying.

Who should be more cautious? Anyone whose need is simple remittance rather than equity management, since that is not what Rovia is for. And anyone uncomfortable being an early user. As a newer company, Rovia is still building track record, and the cross-border equity and tax flows it touches are intricate. That is not a reason to dismiss it, but it is a reason to start small, read the fine print, and keep your own advisor in the loop rather than treating any dashboard as a substitute for personal tax advice.

The honest read

Rovia is solving a real and under-served problem. Plenty of NRIs and globally mobile professionals genuinely are sitting on concentrated RSU positions with no clean way to see, move and diversify them across borders, and a purpose-built tool for that is a sensible idea. The published, capped fee schedule and the use of an established custodian for asset-holding are reassuring signals, and the focus on the India-US corridor matches a real audience.

The honest caveat is simply maturity. Rovia is early-stage, much of what can be verified comes from its own pages rather than independent sources, and regulatory protection that applies to a US resident may not map cleanly onto your situation as an NRI or returning resident. So use it for what it clearly offers, a clearer view of your equity and tools to think through diversification, but verify the rest yourself before you transfer shares or move money.

A few companions worth reading alongside it. If RSUs are the core of your wealth, the tax treatment is the part that quietly decides your outcome, so start with RSU and ESOP taxation for NRIs. If you plan to hold or trade Indian listed equity too, the NRI demat account setup guide covers the account plumbing on the India side. And to judge whether diversifying out of your employer stock is the right call at all, return to the NRI portfolio and asset allocation guide. Rovia can help you act; these help you decide whether to.